{"id":"https://openalex.org/W4388082098","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1116","title":"1116 VAX014 as a novel oncolytic agent for STING and RIG-I-positive solid tumors","display_name":"1116 VAX014 as a novel oncolytic agent for STING and RIG-I-positive solid tumors","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388082098","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1116"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1116","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1116","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1116","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1229.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1229.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006903694","display_name":"Kinsey L. Nelson","orcid":"https://orcid.org/0000-0003-4292-7325","observed_orcids":["https://orcid.org/0000-0003-4292-7325"]},"institutions":[{"id":"https://openalex.org/I4210165428","display_name":"Vaxiion Therapeutics (United States)","ror":"https://ror.org/05fwx1x78","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165428"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kinsey Nelson","raw_affiliation_strings":["Vaxiion Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxiion Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210165428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113034451","display_name":"Amanda M. Parikh","orcid":"https://orcid.org/0009-0002-2391-3622","observed_orcids":["https://orcid.org/0009-0002-2391-3622"]},"institutions":[{"id":"https://openalex.org/I4210165428","display_name":"Vaxiion Therapeutics (United States)","ror":"https://ror.org/05fwx1x78","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165428"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Parikh","raw_affiliation_strings":["Vaxiion Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxiion Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210165428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060389174","display_name":"Shingo Tsuji","orcid":"https://orcid.org/0000-0003-0598-3694","observed_orcids":["https://orcid.org/0000-0003-0598-3694"]},"institutions":[{"id":"https://openalex.org/I4210165428","display_name":"Vaxiion Therapeutics (United States)","ror":"https://ror.org/05fwx1x78","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165428"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shingo Tsuji","raw_affiliation_strings":["Vaxiion Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxiion Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210165428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076451685","display_name":"Katherine A. Reil","orcid":"https://orcid.org/0000-0002-0255-6315","observed_orcids":["https://orcid.org/0000-0002-0255-6315"]},"institutions":[{"id":"https://openalex.org/I4210165428","display_name":"Vaxiion Therapeutics (United States)","ror":"https://ror.org/05fwx1x78","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165428"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine A Reil","raw_affiliation_strings":["Vaxiion Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxiion Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210165428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059436422","display_name":"Carrie Danielle House","orcid":"https://orcid.org/0000-0002-1870-5872","observed_orcids":["https://orcid.org/0000-0002-1870-5872"]},"institutions":[{"id":"https://openalex.org/I26538001","display_name":"San Diego State University","ror":"https://ror.org/0264fdx42","country_code":"US","type":"education","lineage":["https://openalex.org/I26538001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie D House","raw_affiliation_strings":["San Diego State University, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego State University, San Diego, CA, USA","institution_ids":["https://openalex.org/I26538001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055383437","display_name":"Kathleen L. McGuire","orcid":"https://orcid.org/0000-0002-5357-3721","observed_orcids":["https://orcid.org/0000-0002-5357-3721"]},"institutions":[{"id":"https://openalex.org/I26538001","display_name":"San Diego State University","ror":"https://ror.org/0264fdx42","country_code":"US","type":"education","lineage":["https://openalex.org/I26538001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen L McGuire","raw_affiliation_strings":["San Diego State University, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego State University, San Diego, CA, USA","institution_ids":["https://openalex.org/I26538001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068096782","display_name":"Matthew J. Giacalone","orcid":"https://orcid.org/0000-0001-8979-115X","observed_orcids":["https://orcid.org/0000-0001-8979-115X"]},"institutions":[{"id":"https://openalex.org/I4210165428","display_name":"Vaxiion Therapeutics (United States)","ror":"https://ror.org/05fwx1x78","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165428"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Giacalone","raw_affiliation_strings":["Vaxiion Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaxiion Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210165428"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1229","last_page":"A1229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.736299991607666,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.736299991607666,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.10220000147819519,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.042500000447034836,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-virotherapy","display_name":"oncolytic virotherapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/sting","display_name":"STING","score":0.8429999947547913},{"id":"https://openalex.org/keywords/rig-i","display_name":"RIG-I","score":1.0},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cgas-sting-pathway","display_name":"cGAS-STING pathway","score":0.7630000114440918},{"id":"https://openalex.org/keywords/perfringolysin-o","display_name":"perfringolysin O","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tbk1","display_name":"TBK1","score":0.7009999752044678},{"id":"https://openalex.org/keywords/pd-l1-upregulation","display_name":"PD-L1 upregulation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/mhc-class-i-upregulation","display_name":"MHC class I upregulation","score":0.8479999899864197},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.7870000004768372},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.4059999883174896},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.9161501526832581},{"id":"https://openalex.org/C2779300339","wikidata":"https://www.wikidata.org/wiki/Q7617409","display_name":"Sting","level":2,"score":0.7080466151237488},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6657090187072754},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5720285773277283},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5480312705039978},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4515600800514221},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4230755567550659},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3633291721343994},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3472139239311218},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.26873353123664856},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.1479758620262146},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12194037437438965},{"id":"https://openalex.org/C146978453","wikidata":"https://www.wikidata.org/wiki/Q3798668","display_name":"Aerospace engineering","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1116","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1116","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1116","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1229.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:05d8f289e83a4ecf8b1de1bfc4f5c7c3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/05d8f289e83a4ecf8b1de1bfc4f5c7c3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1116","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1116","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1116","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A1229.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309507","display_name":"San Diego State University","ror":"https://ror.org/0264fdx42"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388082098.pdf","grobid_xml":"https://content.openalex.org/works/W4388082098.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W4213292068","https://openalex.org/W4281759495","https://openalex.org/W4293088736"],"related_works":["https://openalex.org/W4406842676","https://openalex.org/W4404052715","https://openalex.org/W4404053235","https://openalex.org/W4310463322","https://openalex.org/W4392138489","https://openalex.org/W2939219629","https://openalex.org/W2482020736","https://openalex.org/W2148482462","https://openalex.org/W4388923639","https://openalex.org/W6903504627"],"abstract_inverted_index":{"Background":[0],"Oncolytic":[1],"virus":[2,490],"(OV)-based":[3],"therapies":[4],"have":[5],"demonstrated":[6,198],"considerable":[7],"promise":[8],"for":[9,420],"treating":[10],"various":[11],"solid":[12,30],"tumor":[13,78,89,139,160,179,286,292,327,394],"types.":[14],"However,":[15],"mounting":[16],"evidence":[17],"indicates":[18],"OVs":[19],"are":[20],"negatively":[21],"impacted":[22],"by":[23,435],"Type":[24,217,259,386],"I":[25,218,260,387],"interferon(s)":[26],"(IFN)":[27],"produced":[28],"in":[29,100,103,112,127,144,145,150,215,273,341,545,553],"tumors":[31,312],"with":[32,228,300,390,512],"functional":[33,129],"cytosolic":[34],"nucleic":[35],"acid":[36],"sensing":[37],"mechanisms,":[38],"including":[39],"the":[40,84,95,166,280,324,337,352,359],"cGAS/STING":[41],"and/or":[42,163,364],"RIG-I":[43,93,111,164,206,237,331,356,365,382],"pathways.1":[44],"2":[45],"VAX014":[46,99,169,307,349,372,510,543],"is":[47,61],"a":[48,67,216,315],"novel,":[49],"clinical":[50],"stage":[51],"oncolytic":[52,69,489],"agent":[53],"based":[54],"on":[55,94,165],"recombinant":[56],"bacterial":[57],"minicells":[58],"(rBMCs)":[59],"and":[60,65,86,92,102,136,182,190,205,210,213,220,240,263,283,335,355,358,381,384,416,424,443,492,518,548],"designed":[62],"to":[63,76,131,155,174,255,295,308,314,339,367,400,410,464,515],"target":[64],"deliver":[66],"pre-formed":[68],"protein":[70],"toxin,":[71],"perfringolysin":[72],"O":[73],"(PFO),":[74],"directly":[75],"integrin-expressing":[77],"cells.3":[79],"4":[80],"Here":[81],"we":[82],"characterize":[83],"interaction":[85],"impact":[87],"of":[88,98,108,159,168,233,252,258,271,306,326,361,371,393,426,521,542],"intrinsic":[90,161,328],"STING":[91,109,162,204,235,272,329,354,363,380],"antitumor":[96,369,402],"activity":[97,370],"vitro":[101,128,196],"vivo.":[104],"Methods":[105],"Targeted":[106,230],"deletion":[107],"or":[110,236,330,344],"wild":[113,151,191,199,296,309],"type":[114,152,192,200,297,310],"MB49":[115,201,311],"murine":[116,353],"urothelial":[117],"carcinoma":[118],"cells":[119,202],"was":[120,433],"performed":[121],"via":[122],"CRISPR-Cas9.":[123],"Following":[124],"extensive":[125],"orthogonal":[126],"characterization":[130],"confirm":[132],"genotype/phenotype,":[133],"MB49STING":[134,247,281,342],"KO":[135,138,239,248,275,282,285,343,346],"MB49RIG-I":[137,241,274,284,345],"cell":[140,287,404],"lines":[141,288],"were":[142,185],"utilized":[143],"vivo":[146],"preclinical":[147],"pharmacology":[148],"studies":[149],"C57BL/6":[153],"mice":[154],"assess":[156],"any":[157],"influence":[158],"efficacy":[167],"following":[170,226,373],"intratumoral":[171],"(i.t.)":[172],"administration":[173,305,541],"intradermal":[175],"(i.d.)":[176],"tumors.":[177,347,556],"Individual":[178],"growth":[180,293],"rates":[181,294,334],"survival":[183],"curves":[184],"plotted":[186],"against":[187],"respective":[188],"saline":[189],"controls.":[193],"Results":[194],"In":[195,246,277,322],"analysis":[197],"express":[203],"(but":[207],"not":[208],"cGAS)":[209],"upregulate":[211],"PD-L1":[212,513],"MHC-I":[214],"IFN":[219,261,388],"Tank-binding":[221],"kinase-1":[222],"(TBK-1)":[223],"dependent":[224],"manner":[225],"treatment":[227],"VAX014.":[229],"genetic":[231],"ablation":[232],"either":[234],"(MB49STING":[238],"KO)":[242],"reduced":[243,332],"this":[244],"response.":[245],"cells,":[249],"pharmacologic":[250,269],"inhibition":[251,270],"TBK-1":[253],"led":[254,313],"complete":[256,318],"elimination":[257],"production":[262,389],"subsequent":[264,385],"PD-L1/MHC-I":[265],"upregulation,":[266],"as":[267],"did":[268],"cells.":[276],"vivo,":[278],"both":[279,351],"had":[289],"similar":[290],"i.d.":[291],"MB49.":[298],"Consistent":[299],"previous":[301],"work,":[302],"weekly":[303],"i.t.":[304,374],"100%":[316],"durable":[317],"response":[319],"(CR)":[320],"rate.":[321],"contrast,":[323],"loss":[325],"CR":[333],"lengthened":[336],"time":[338],"respond":[340],"Conclusions":[348],"activates":[350],"pathways":[357],"presence":[360],"tumor-intrinsic":[362],"leads":[366],"optimal":[368],"administration.":[375],"This":[376,431],"unique":[377],"mechanism":[378],"pairs":[379],"agonism":[383],"oncolysis-mediated":[391],"availability":[392],"antigens,":[395],"which":[396],"together,":[397],"may":[398],"lead":[399],"better":[401],"T":[403],"priming.":[405],"Acknowledgements":[406],"We":[407],"would":[408],"like":[409],"acknowledge":[411],"Steven":[412],"N.":[413],"Fiering,":[414],"Ph.D":[415,419],"Trevor":[417],"Hallam,":[418],"useful":[421],"discussions,":[422],"review,":[423],"interpretation":[425],"study":[427,432],"data.":[428],"Ethics":[429],"Approval":[430],"approved":[434,447],"San":[436],"Diego":[437],"State":[438],"University\u2019s":[439],"Institutional":[440],"Animal":[441,448],"Care":[442],"Use":[444],"Committee":[445],"under":[446],"Protocol":[449],"number":[450],"IACUC-22\u2013064.":[451],"References":[452],"Kaufman":[453],"HL,":[454],"Shalhout":[455],"SZ,":[456],"Iodice":[457],"G.":[458],"Talimogene":[459],"Laherparepvec:":[460],"Moving":[461],"From":[462],"First-In-Class":[463],"Best-In-Class.":[465],"Front.":[466,494],"Mol.":[467],"Biosci.":[468],"2022;9:834841":[469],"Li":[470],"Q,":[471],"Tan":[472],"F,":[473],"Wang":[474],"Y,":[475],"Liu":[476],"X,":[477,479],"Kong":[478],"Meng":[480],"J,":[481],"Yang":[482],"L,":[483],"Cen":[484],"S.":[485],"The":[486],"gamble":[487],"between":[488],"therapy":[491],"IFN.":[493],"Immunol.":[495],"2022;13:971674":[496],"Tsuji":[497,530],"S,":[498,531],"Reil":[499,528],"KA,":[500,529],"Nelson":[501,534],"K,":[502],"Proclivo":[503],"VH,":[504],"McGuire":[505,536],"KL,":[506,535,537],"Giacalone":[507,538],"MJ.":[508,539],"Intravesical":[509],"Synergizes":[511],"Blockade":[514],"Enhance":[516],"Local":[517],"Systemic":[519],"Control":[520],"Bladder":[522],"Cancer.":[523,559],"Cancer":[524],"Imunol.":[525],"Res.":[526],"2022;10:978\u201395.":[527],"Molina":[532],"E,":[533],"Intralesional":[540],"facilitates":[544],"situ":[546],"immunization":[547],"potentiates":[549],"immune":[550],"checkpoint":[551],"blockade":[552],"immunologically":[554],"cold":[555],"J.":[557],"Immunother":[558],"11:e006749":[560]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-01T00:00:00"}